Stefan Glombitza is the founder of Formycon. Latest round: IPO. Backed by ATHOS, Wendel. Based in Planegg, Bavaria, Germany.
Stefan Glombitza is the CEO of Formycon AG, a leading independent developer of high-quality biosimilars. He joined Formycon in 2016, initially as Chief Operating Officer, and was appointed CEO in July 2022. With over 25 years of experience in the international pharmaceutical industry, he has been instrumental in the development and growth of Formycon, leading to approvals for three biosimilars and guiding the company into the commercial stage.
Full founder directory · Investor directory · Company funding database · Fundraising library